enGene Therapeutics, Inc. (ENGN)
1.81
+0.03
(+1.69%)
USD |
NASDAQ |
Aug 24, 16:00
1.82
+0.01
(+0.55%)
After-Hours: 20:00
enGene Therapeutics Total Assets (Quarterly) : 307.52M for April 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 307.52M |
| January 31, 2026 | 337.11M |
| October 31, 2025 | 221.47M |
| July 31, 2025 | 245.55M |
| April 30, 2025 | 266.65M |
| January 31, 2025 | 285.93M |
| October 31, 2024 | 311.17M |
| July 31, 2024 | 266.88M |
| April 30, 2024 | 273.53M |
| January 31, 2024 | 93.42M |
| October 31, 2023 |
| Date | Value |
|---|---|
| September 30, 2023 | 138.95M |
| July 31, 2023 | 0.00 |
| June 30, 2023 | 136.10M |
| March 31, 2023 | 133.56M |
| December 31, 2022 | 132.04M |
| September 30, 2022 | 131.21M |
| June 30, 2022 | 131.06M |
| March 31, 2022 | 131.24M |
| December 31, 2021 | 131.45M |
| September 30, 2021 | 0.3546M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 792.26M |
| Medicus Pharma Ltd. | 19.11M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.296B |
| Psyence Biomedical Ltd. | 12.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 52.36M |
| Shareholders Equity (Quarterly) | 255.17M |
| Debt to Equity Ratio | 0.1307 |
| Current Ratio | 12.57 |
| Net Debt Paydown Yield | -0.34% |